Table 1 Clinical profiles of the patients before oral semaglutide administration
From: Oral semaglutide in kidney transplant recipients with metabolic syndrome: three Japanese cases
Case 1 | Case 3 | Case 3 | |
|---|---|---|---|
Gender | Male | Male | Male |
Age (years) | 52 | 62 | 59 |
Primary renal disease | CGN | IgAN | IgAN |
Period after transplantation (years) | 4.6 | 25.4 | 23.5 |
Waist circumference (cm) | 114 | 91 | 102 |
Immunosuppressant | PSL, TAC, MZR, EVR | PSL, CyA, MMF, EVR | PSL, CyA, MZR, EVR |
Concomitant drugs | Febuxostat Fluvastatin Ezetimibe | Febuxostat Fluvastatin Cilnidipine Valsartan | Febuxostat Fluvastatin Cilnidipine Valsartan, amlodipine |
Complications | MetS, PTDM, HT Dyslipidemia C9 deficiency | MetS, HT, HU Dyslipidemia | MetS, HT,HU Fatty liver Dyslipidemia |
Family history | DM(-) Renal disease(-) | DM(-) Renal disease(-) | DM(-) Renal disease(-) |
Past history | Gastroduodenal ulcer | Hypouricemia | Hopes zoster |